TRIDENT studie publicaties

MN Bekker, L Henneman, MVE. Macville, EA. Sistermans, RJH Galjaard. Benefit vs potential harm of genome-wide prenatal cfDNA testing requires further investigation and should not be dismissed based on current data. Ultrasound Obstet Gynecol. 2020 May;55(5):695-696.

Henneman L, Van Opstal D, Macville M, Sistermans E, Galjaard R-J, Bekker MN, Bax CJ. Nevenbevindingen bij de NIPT. Nederlands Tijdschrift voor Obstetrie en Gynaecologie. 2020;1:12-13.

Van der Meij KRM, Sistermans EA, Macville MVE, Stevens SJC, Bax CJ, Bekker MN, Bilardo CM, Boon EMJ, Boter M, Diderich KEM, de Die-Smulders CEM, Duin LK, Faas BHW, Feenstra I, Haak MC, Hoffer MJV, den Hollander NS, Hollink IHIM, Jehee FS, Knapen MFCM, Kooper AJA, van Langen IM, Lichtenbelt KD, Linskens IH, van Maarle MC, Oepkes D, Pieters MJ, Schuring-Blom GH, Sikkel E, Sikkema-Raddatz B, Smeets DFCM, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Ven AJEM, van Zelderen-Bhola SL, Henneman L, Galjaard RH, Van Opstal D, Weiss MM; Dutch NIPT Consortium. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands. Am J Hum Genet. 2019 Dec 5;105(6):1091-1101

Saes L, Govaerts LCP, Knapen MFCM, Lugtenburg PJ, Boere IA, Galjaard RH. Incidental detection of maternal malignancy in non-invasive prenatal test. Ned Tijdschrift Geneeskd. 2019 Jan 24;163. pii:D2779. Dutch.

Henneman L, Macville M, Van Opstal D, van der Ven J, Sistermans E, Galjaard R-J. Het dilemma van de keuze. Nevenbevindingen bij de NIPT. Tijdschrift voor Verloskundigen 2019;1:6-10.

Huijsdens-van Amsterdam K, Straver R, van Maarle MC, Knegt AC, Van Opstal D, Sleutels F, Smeets D, Sistermans EA. Mosaic maternal 10qter deletions are associated with FRA10B expansions and may cause false-positive noninvasive prenatal screening results. Genet Med. 2018;20:1472-1476

Van Opstal D, van Maarle MC, Lichtenbelt K, Weiss MM, Schuring-Blom H, Bhola SL, Hoffer MJV, Huijsdens-van Amsterdam K, Macville MV, Kooper AJA, Faas BHW,  Govaerts L, Tan-Sindhunata GM, den Hollander N, Feenstra I, Galjaard RJH, Oepkes D, Ghesquiere S, Brouwer RWW, Beulen L, Bollen S, Elferink MG,  Straver R, Henneman L, Page-Christiaens GC, Sistermans EA, for the Dutch NIPT Consortium. Origin and clinical relevance of chromosomal aberrations other than the common trisomies detected by genome-wide NIPT: results of the TRIDENT study. Genet Med. 2018;20:480-485.

Van Schendel RV, Page-Christiaens L, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MV, Oepkes D, Pajkrt E, Henneman L for the Dutch NIPT Consortium. Women’s experience with NIPT and emotional wellbeing and satisfaction after test results. J Genet Couns 2017;26:1348-1356

Tamminga S, van Dussen L, Verweij EJ, de Boer MA, Cornel MC, Henneman L, Dutch NIPT Consortium. What do people want to know about NIPT? Content analysis of questions emailed to national NIPT information websites. Prenat Diagn 2017;37:412-415.

Sistermans EA, Galjaard RJ, Scheffer H, Henneman L, on behalf of the NIPT Consortium. The Dutch TRIDENT studies: Implementing NIPT as part of the national prenatal screening program. Global Updates. Official Newsletter of the International Society for Prenatal Diagnosis. June 2017

Oepkes D, Page-Christiaens LC, Bax CJ, Bekker MN, Bilardo CM, Boon EM, Schuring-Blom GH, Coumans AB, Faas BH, Galjaard RH, Go AT, Henneman L, Macville MV, Pajkrt E, Suijkerbuijk RF, Huijsdens-vanAmsterdam K, Van Opstal D, Verweij EJ, Weiss MM, Sistermans EA; Dutch NIPT Consortium.Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part I – Clinical Impact. Prenat Diagn 2016;36:1083-1090.

van Schendel RV, Page-Christiaens L, Beulen L, Bilardo CM, de Boer MA, Coumans AB, Faas BH, van Langen IM, Lichtenbelt KD, van Maarle MC, Macville MV, Oepkes D, Pajkrt E, Henneman L; Dutch NIPT Consortium. Trial by Dutch Laboratories for Evaluation of Non-Invasive Prenatal Testing. Part II – Women’s Perspectives. Prenat Diagn 2016;36:1091-1098.

Bax CJ, Henneman L. Implementatie van de niet-invasieve prenatale test (NIPT) in Nederland. Ned Tijdschr Obstet Gyn. 2016;129: 477-478.

Henneman L, Page-Christiaens GC, Oepkes D. [Non-invasive prenatal testing: challenges for future implementation]. Ned Tijdschr Geneeskd. 2015;159:A9479. In Dutch.

Christiaens G, Galjaard RJ, Henneman L, Oepkes D, Schuring-Blom H., Sistermans E, on behalf of the NIPT consortium. Introducing noninvasive prenatal testing (NIPT) for fetal aneuploidy in the Netherlands. Prenatal Perspectives, Official Newsletter of the International Society for Prenatal Diagnosis. Volume 2 (1); 2014, p. 9-10.